LATEST WEBINARS
Live event: Tuesday 22 August 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
All biological protein drugs are immunogenic, which may lead to severe clinical consequences. This makes knowledge of the scientific and regulatory aspects of immunogenicity a must for every drug manufacturer.
In this webinar, Adam Hill from Prospective Reseach (MA, USA) discusses the changes and challenges in early drug discovery. Early drug discovery sets the foundation for the successful delivery of novel medicines to improve the quality of human life. The science for targeting new diseases has changed dramatically over the last five years, with more changes to come. The new challenges and limitations facing researchers in early drug discovery will be discussed in the context of the conventional technologies that exist, and where the need for disruptive technologies is most pressing
Available to view on demand
In this panel discussion our experts will analyze the results from our recent survey on the bioanalysis of biopharmaceuticals and biomarkers, providing a comprehensive overview and focusing on developing technologies and trends.
Available to view on demand
In this mini-webinar you will learn about different LC-MS/MS approaches for quantitative protein bioanalysis with focus on biopharmaceuticals, biomarkers and targeted proteomics.
Available to view on demand
Attendees will learn our laboratory’s approach for designing, calibrating, and implementing protein quantitation assays in proteomics.
Available to view on demand
Our experts discuss what the future holds for outsourcing in the next ten years and the implications this will have on the industry for CRO and Pharma.
Available to view on demand
Avoid preclinical testing failure by understanding the complex bioanalytical and toxicology challenges associated with ADC drug development and unique ways to overcome them.
Latest News
The assay development company, SISCAPA Assay Technologies Inc., announce that Waters Corporation have obtained a license for liquid chromatography and mass spectrometry assay technology.
Bioanalysis Zone and the University of Wisconsin-Madison’s School of Pharmacy are delighted to present a collection of informative webinars on the latest hot topic areas for the bioanalytical community.
Researchers from the University of Malaya (Kuala Lumpur, Malaysia) have developed a new electrochemical immunosensor that can quantify concentrations of biotin in serum.
Latest Features
Bioanalysis Zone are delighted to partner with The Chromatographic Society at the 22nd International Reid Bioanalytical Forum (4–7 September; Cambourne, UK). We have the pleasure of publishing exclusive content and presentations directly from Reid, including a live stream from the first talk, ‘Bioanalysis of the future’.
In this article, Eric Tewalt and James Gorman discuss updates and considerations for the utilization of hybridization ELISA methods, including associated benefits and challenges, for the bioanalysis of oligonucleotides.
We interviewed Joe Rajarao, Client Engagement Manager at IDBS, who discusses how the use of technology, specifically software, can impact the bioanalytical field.
Automation
Novel inertial microfluidic device could enhance sorting and purification of cells
Automation in Chinese bioanalytical CROs for sustained competitiveness and growth
Chromatography
Researchers identify candidate biomarkers for onset of osteoporosis
Could metabolomic profiling lead to earlier diagnosis of H1N1 influenza pneumonia?
Clinical
Could a blood test detect the risk of cardiovascular disease in asymptomatic patients with lupus?
Could eosinophils be biomarkers for chronic obstructive pulmonary disease?
Collaborations and Mergers
PerkinElmer increases diagnostic capacities with acquisition of EUROIMMUN for $1.3 billion
Charles River partners with OcellO to expand oncology business
Data Processing / Interpretation
Immunosensor developed for biotin detection
Drug Discovery and Development
Recent aspects and challenges in the assessment of immunogenicity
BIOCAD’s rituximab biosimilar receives recommendation for approval in India
‘Heart-on-a-chip’ engineered by Lawrence Livermore researchers
Forensic
Forensic scientists develop a new technique to distinguish the origins of bodily fluids
Disease pathogens rapidly detected by new test
Fingerprints: biological samples for identification of sex and, potentially, more
Imaging
Could chemiluminescence detect cancer?
Lung cancer recurrence detected earlier by circulating tumor cell test
Brain tumor progression and response to treatment tracked by new imaging biomarker
Ligand-binding
Mass Spectrometry
Insulin bioanalysis workflows simplified by new ready-to-use mass spectromic kit
Researchers identify candidate biomarkers for onset of osteoporosis
Other
Poster presentations from the 11th Workshop on Recent Issues in Bioanalysis (WRIB)
BioPharmaSpec announce new in-house analytical services
TRUE-AHF is latest CRO-led international clinical trial reported to lack integrity
Regulated Bioanalysis
Study shows similarity in efficacy and safety between trastuzumab and its biosimilar candidate
FDA approval for first cancer treatment targeting solid tumors based on genetic characteristics
Pfizer’s proposed biosimilar secures approval from FDA advisory committee
Sample preparation, extraction & collection
Sports Drug Testing
Microsampling in sports drug testing – an interview with Laura Mercolini (University of Bologna)
Q&A With Monica Mazzarino & Franscisco Radler on key anti-doping issues
Toxicology
Bioanalysis and toxicology challenges with ADC: how are they different and new?